B3 · BRL
DMVF3
D1000 Varejo Farma Participacoes SA
- Day's range
- R$6.00 – R$6.17
- Day's volume
- R$236.6k
- 52-week range
- R$4.51 – R$7.50
Follow DMVF3 on Fuolio
See how DMVF3 weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountDMVF3 in numbers
- Market cap
- R$306.1m
- P/E
- 14.08
- P/B
- 0.33
- Dividend yield (12m)
- 0.00%
- Net debt/EBITDA
- 0.14
DMVF3 trades at 14.08 times its earnings of the last 12 months.
DMVF3 price history
DMVF3 risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +11.42% | +46.49% | +15.90% |
| Volatility (annualised) | 25.47% | 31.24% | 33.67% |
| Largest drawdown | -21.87% | -37.52% | -37.52% |
| Positive months | 7/12 | 19/36 | 29/60 |
How much did investing in DMVF3 return?
R$1,000.00 invested on 01/10/2021 would be worth R$1,159.00 today.
- Value today in DMVF3
- R$1,159.00
- Return over the period
- +15.90%
- Return per year
- +3.00%
- In the Ibovespa
- R$1,777.43
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
DMVF3 fundamentals
Valuation
- P/E14.08
- P/B0.33
- EV/EBITDA1.45
- EV/EBIT3.76
- EV/Revenue0.12
- P/EBIT3.39
- P/S0.11
- P/OCF1.48
- P/FCF3.06
- Earnings yield26.62%
- PEG ratio1.20
- Earnings per shareR$0.43
- Book value per shareR$18.26
Debt
- Net debtR$33.2m
- Net debt/EBITDA0.14
- Net debt/Equity0.04
- Debt/Equity0.06
- Current ratio1.01
- Quick ratio0.54
- Cash ratio0.04
Efficiency
- Gross margin29.63%
- EBITDA margin8.48%
- Operating margin3.28%
- Net margin0.79%
- Asset turnover1.36
Profitability
- ROE2.35%
- ROA1.07%
- ROIC9.44%
- Payout0.00%
Growth
- Revenue CAGR (5 years)21.54%
- Earnings CAGR (5 years)21.94%
- Revenue growth (year)23.42%
- Earnings growth (year)-12.73%
- Revenue growth (quarter)14.10%
- Earnings growth (quarter)11.85%
What is DMVF3's fair price?
Two classic value formulas, with today's numbers. The current price is R$6.05.
- Graham's fair price
- R$13.29
- 119.60% above the price
√(22.50 × R$0.43 × R$18.26)
Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.
- Bazin's ceiling price
- —
- Does not apply to DMVF3: it paid no distributions in the last five years.
Décio Bazin only bought shares yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years divided by 6%.
Graham ignores growth and debt; Bazin assumes past distributions will repeat. They are reference points for comparison, not a buy recommendation.
DMVF3 indicators by year
Multiples at each year's closing price; margins and returns from that year's accounts.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| P/E | 15.47 | 12.04 | 14.05 | 18.23 | 109.69 | 5,257.76 | — |
| P/B | 0.38 | 0.35 | 0.34 | 0.24 | 0.26 | 0.77 | — |
| EV/EBITDA | 1.71 | 1.62 | 1.81 | 1.35 | 1.87 | 6.84 | — |
| Earnings per share | R$0.45 | R$0.51 | R$0.42 | R$0.22 | R$0.04 | R$0.00 | -R$0.15 |
| Book value per share | R$18.17 | R$17.72 | R$17.21 | R$16.79 | R$16.56 | R$16.52 | R$9.21 |
| ROE | 2.45% | 2.88% | 2.45% | 1.34% | 0.24% | 0.01% | -1.61% |
| ROIC | 8.88% | 6.54% | 4.89% | 3.85% | 0.00% | 0.00% | 0.00% |
| Gross margin | 28.58% | 30.62% | 31.61% | 32.06% | 32.50% | 32.35% | 30.20% |
| EBITDA margin | 8.20% | 8.37% | 8.91% | 8.97% | 8.05% | 8.32% | 7.46% |
| Net margin | 0.85% | 1.20% | 1.22% | 0.77% | 0.17% | 0.01% | -0.66% |
| Net debt/EBITDA | 0.12 | -0.10 | -0.11 | -0.21 | -0.49 | -0.90 | 2.01 |
DMVF3 financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | R$2.7bn | R$2.2bn | R$1.7bn | R$1.5bn | R$1.1bn | R$1bn |
| Cost of sales | -R$1.9bn | -R$1.5bn | -R$1.2bn | -R$1bn | -R$770.5m | -R$679.5m |
| Gross profit | R$762.2m | R$661.6m | R$552.8m | R$475.5m | R$370.9m | R$324.9m |
| EBITDA | R$218.6m | R$180.9m | R$155.9m | R$133.1m | R$91.9m | R$83.6m |
| EBIT | R$83.9m | R$63.2m | R$51.3m | R$35.6m | -R$2.1m | R$6.6m |
| Net finance result | -R$64.1m | -R$34.8m | -R$25.1m | -R$22.9m | -R$17.1m | -R$24.4m |
| Profit before tax | R$19.8m | R$28.5m | R$26.3m | R$12.8m | -R$19.2m | -R$17.8m |
| Income tax | R$2.8m | -R$2.6m | -R$4.9m | -R$1.4m | R$21.2m | R$17.9m |
| Net income | R$22.6m | R$25.9m | R$21.4m | R$11.4m | R$2m | R$123k |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
DMVF3 against its sector
The same indicators for the company's other shares and the sector's largest stocks.
| Stock | P/E | P/B | Dividend yield (12m) | ROE | Market cap |
|---|---|---|---|---|---|
| DMVF3D1000 Varejo Farma Participações | 14.08 | 0.33 | 0.00% | 2.35% | R$306.1m |
| BEEF3MINERVA S.A. | 8.60 | 2.50 | 4.97% | 29.04% | R$3.9bn |
| RIAA3RIAA3 | 2.35 | 0.67 | 45.40% | 28.35% | R$3.6bn |
| PFRM3PROFARMA DISTRIB PROD FARMACEUTICOS S.A. | 5.92 | 0.63 | 8.72% | 10.71% | R$915m |
| WLMM4WLM PART. E COMÉRCIO DE MÁQUINAS E VEÍCULOS S.A. | 7.35 | 0.71 | 12.42% | 9.63% | R$589.4m |
| WLMM3WLM PART. E COMÉRCIO DE MÁQUINAS E VEÍCULOS S.A. | 7.74 | 0.75 | 10.71% | 9.63% | R$589.4m |
Does DMVF3 pay dividends?
DMVF3 has no distributions on record.
About D1000 Varejo Farma Participações
- Sector
- Consumo Não Cíclico
- Segment
- Medicamentos e Outros Produtos
- Listing segment
- Novo Mercado
- Tag along
- 100.00%
- Free float
- 33.24%
- Shares issued
- 50.6m ordinary
- Average daily trading
- R$241.9k
- Listed since
- 10/08/2020
- CNPJ
- 12.108.897/0001-50
A D1000 Varejo Farma Participações S.A. atua no varejo farmacêutico com operação de redes de drogarias, comercializando medicamentos de prescrição, genéricos, OTC, higiene pessoal, perfumaria e itens de conveniência em lojas físicas e canais digitais. A companhia possui presença relevante em regiões urbanas de alta densidade, com modelo focado em giro de estoque, gestão de categorias e relacionamento de proximidade com o consumidor final. No segmento de consumo não cíclico, o negócio é influenciado por mix de produtos, política comercial de laboratórios, eficiência logística e despesas de ocupação das lojas. A empresa concorre com grandes cadeias nacionais e operadores regionais, buscando escala por expansão orgânica e aprimoramento de produtividade por ponto de venda. O desempenho também depende de margens de medicamentos, fidelização e capacidade de execução omnicanal.
Investor website| Shareholder | Ordinary | Preferred | Total |
|---|---|---|---|
| PROFARMA DISTRIBUIDORA DE PRODUTOS FARMACÊUTICOS S.A.Controlling | 72.31% | 0.00% | 72.31% |
| LIS Capital Gestora Ltda | 7.77% | 0.00% | 7.77% |
| Outros | 19.93% | 0.00% | 19.93% |
Questions about DMVF3
How much is DMVF3 today?
DMVF3 is at R$6.05 (-1.14% on the day), last traded on 30/09/2026.
What are the P/E and P/B of DMVF3?
DMVF3 trades at a P/E of 14.08 and a P/B of 0.33.
How much did DMVF3 return in 12 months?
DMVF3 returned 11.42% in 12 months, with annualised volatility of 25.47% and a largest drawdown of -21.87%.
What sector is DMVF3 in?
D1000 Varejo Farma Participações is in the Consumo Não Cíclico sector, Medicamentos e Outros Produtos segment.